19SEPTEMBER 2026capacity of 10,000MTPA to 18,000 MTPA, with two dedicated lines - one for medical applications and another for hygiene. The expansion will allow the company to serve both segments with capabilities tailored to their distinct requirements. They expect this capacity to come online in early September 2026.The business is also building a measured international presence. Exports currently account for around 15 percent of output, with the company targeting 25 percent by the end of FY27 on the increased capacity. India will remain its primary market, but the growing export share allows Manjushree Spntek to take its technical capabilities into markets where performance standards are already high.What stands out is the speed at which the company has established its position. Kedia describes his company as - one of the youngest players in India's nonwoven industry,and it is already bringing thought leadership in pricing, product development and emerging material trends."We are the ones who set the trends; who set the benchmark for pricing for the industry and we are the ones who are leading from the front", concludes Rajat .For Kedia, however, industry leadership is not only about the company's own growth. He sees a need for Indian manufacturers to move beyond competing primarily on price and raise the product offering and quality of materials - available to the market. That shift would bring domestic medical and hygiene products closer to the standards already expected in more developed markets.For Manjushree Spntek, the opportunity is to build on that gap without diluting what made the company distinctive in the first place. Greater capacity can widen its reach, but specialised manufacturing and a disciplined quality culture will determine whether that scale translates into lasting influence. Its next chapter, therefore, is not simply about becoming bigger. It is about proving that an Indian nonwoven manufacturer can set the benchmark rather than follow it. · 2,000 kaizens a year making continuous improvement a recurring operating practice rather than an occasional initiative.· Nearly 600 worker-led improvements demonstrating that process innovation is not confined to managerial or technical teams.· More than 70 medical SKUs reflecting the depth of the company's original medical-first positioning.· 18,000-tonne target capacity representing an 80 percent planned increase from the current 10,000-tonne base.A Closer Look at the Scale
< Page 9 | Page 11 >